[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE3854121D1 - Arzneimittelzusammensetzungen zur behandlung von psoriasis. - Google Patents

Arzneimittelzusammensetzungen zur behandlung von psoriasis.

Info

Publication number
DE3854121D1
DE3854121D1 DE3854121T DE3854121T DE3854121D1 DE 3854121 D1 DE3854121 D1 DE 3854121D1 DE 3854121 T DE3854121 T DE 3854121T DE 3854121 T DE3854121 T DE 3854121T DE 3854121 D1 DE3854121 D1 DE 3854121D1
Authority
DE
Germany
Prior art keywords
medicinal compositions
treating psoriasis
compositions
psoriasis
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3854121T
Other languages
English (en)
Other versions
DE3854121T2 (de
Inventor
Izhak Blank
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dexter Chemical Corp
Original Assignee
Dexter Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dexter Chemical Corp filed Critical Dexter Chemical Corp
Publication of DE3854121D1 publication Critical patent/DE3854121D1/de
Application granted granted Critical
Publication of DE3854121T2 publication Critical patent/DE3854121T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/09—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to carbon atoms of an acyclic unsaturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/49—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/52—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the nitrogen atom of at least one of the carboxamide groups further acylated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE3854121T 1987-09-04 1988-09-01 Arzneimittelzusammensetzungen zur behandlung von psoriasis. Expired - Fee Related DE3854121T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL83775A IL83775A (en) 1987-09-04 1987-09-04 Amino acid esters and amides of fumaric acid and pharmaceutical compositions containing them for use in the treatment of psoriasis
PCT/US1988/002941 WO1989001930A1 (en) 1987-09-04 1988-09-01 Pharmaceutical compositions for the treatment of psoriasis

Publications (2)

Publication Number Publication Date
DE3854121D1 true DE3854121D1 (de) 1995-08-10
DE3854121T2 DE3854121T2 (de) 1996-03-21

Family

ID=11058151

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3854121T Expired - Fee Related DE3854121T2 (de) 1987-09-04 1988-09-01 Arzneimittelzusammensetzungen zur behandlung von psoriasis.

Country Status (14)

Country Link
EP (1) EP0328634B1 (de)
JP (1) JPH0745451B2 (de)
KR (1) KR890701545A (de)
AT (1) ATE124681T1 (de)
AU (1) AU618759B2 (de)
CA (1) CA1340005C (de)
DE (1) DE3854121T2 (de)
DK (1) DK218189A (de)
FI (1) FI891986A0 (de)
IL (1) IL83775A (de)
IN (1) IN167848B (de)
NO (1) NO891703L (de)
WO (1) WO1989001930A1 (de)
ZA (1) ZA886097B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5290769A (en) * 1989-09-27 1994-03-01 Asta Pharma Aktiengesellschaft Use of hexadecylphosphocholine for the treatment of psoriasis
AU1271592A (en) * 1991-01-18 1992-08-27 Dexter Chemical Corporation Malic acid derivatives and compositions for the treatment of psoriasis
US5856418A (en) * 1996-04-16 1999-01-05 Nippon Shokubai Co., Ltd. Water-soluble monomer, water-soluble polymer and their production process and use
DE19853487A1 (de) 1998-11-19 2000-05-25 Fumapharm Ag Muri Verwendung von Dialkylfumaraten
RS52083B (sr) * 2001-01-12 2012-06-30 Fumapharm Ag Amidi fumarne kiseline
DE10217314A1 (de) 2002-04-18 2003-11-13 Fumapharm Ag Muri Carbocyclische und Oxacarboncyclische Fumarsäure-Oligomere
SI1663197T1 (sl) 2003-09-09 2008-06-30 Biogen Idec Internat Gmbh Uporaba derivatov fumarne kisline za zdravljenje sräśne insuficience in astme
FI121915B (fi) * 2004-02-06 2011-06-15 Neurofood Ab Oy Koostumus psoriasiksen hoitoon
ME02746B (de) 2004-10-08 2018-01-20 Forward Pharma As Gesteuerte Freisetzung von pharmazeutischen Zusammensetzungen mit Fumarinsäureester
EP2137537B8 (de) 2007-02-08 2016-06-01 Biogen MA Inc. Zusammensetzungen und deren Verwendung zur Behandlung von Multipler Sklerosis
US20100158829A1 (en) * 2008-12-24 2010-06-24 Conopco, Inc., D/B/A Unilever Method and Composition for Color Modulation
DK2564839T3 (en) 2009-01-09 2016-07-25 Forward Pharma As A pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
ES2637266T3 (es) 2010-01-08 2017-10-11 Catabasis Pharmaceuticals, Inc. Derivados fumarato de ácido graso y sus usos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790032A (fr) * 1971-10-27 1973-02-01 Elf Union Procede de fonctionnement de bruleurs a emulsion a deux allures
JPS4852741A (de) * 1971-11-04 1973-07-24
CA982530A (en) * 1972-05-23 1976-01-27 Roger Grenetier Device for storing and packaging materials
DE2703964A1 (de) * 1975-07-08 1978-08-03 Walter Dr Schweckendiek Pharmazeutische zubereitungen zur behandlung von psoriasis
JPS57102852A (en) * 1980-12-19 1982-06-26 Shionogi & Co Ltd Dicarboxylic acid diamide
US4362737A (en) * 1981-04-13 1982-12-07 Schaefer Rolf Transdermal carrier materials
DE3444915A1 (de) * 1984-12-08 1986-06-12 Hoechst Ag, 6230 Frankfurt N-maleyl-phenylalaninalkylester, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von n-fumarylphenylalaninalkylestern
JPS6248656A (ja) * 1985-08-28 1987-03-03 Showa Denko Kk Ｎ−フマリル−ｌ−フエニルアラニンメチルエステル及びその製法
US4730048A (en) * 1985-12-12 1988-03-08 Regents Of The University Of Minnesota Gut-selective opiates

Also Published As

Publication number Publication date
ATE124681T1 (de) 1995-07-15
KR890701545A (ko) 1989-12-20
EP0328634A4 (en) 1991-08-21
AU618759B2 (en) 1992-01-09
FI891986A (fi) 1989-04-26
WO1989001930A1 (en) 1989-03-09
DE3854121T2 (de) 1996-03-21
ZA886097B (en) 1989-06-28
EP0328634B1 (de) 1995-07-05
NO891703D0 (no) 1989-04-25
JPH0745451B2 (ja) 1995-05-17
IL83775A0 (en) 1988-02-29
JPH02501072A (ja) 1990-04-12
AU2423788A (en) 1989-03-31
DK218189D0 (da) 1989-05-03
EP0328634A1 (de) 1989-08-23
IN167848B (de) 1990-12-29
CA1340005C (en) 1998-08-18
DK218189A (da) 1989-07-03
NO891703L (no) 1989-04-25
IL83775A (en) 1991-12-15
FI891986A0 (fi) 1989-04-26

Similar Documents

Publication Publication Date Title
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
DE122006000010I1 (de) Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3- Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten
DE3856398D1 (de) Verfahren zur Behandlung von Gleitkörpern
DE69106586D1 (de) Verwendung von Baclofen zur Herstellung von Arzneimitteln zur Behandlung von Angina pectoris.
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE85523T1 (de) Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.
ATE173625T1 (de) Zusammensetzungen zur behandlung von hiv- infektionen
DE58907851D1 (de) Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes.
ATE107859T1 (de) Verwendung von antiprogestomimetika zur stimulierung des eisprungs.
PT83309B (de) Neue pyrrolo-benzimidazole pyrrolo-benzoxazole und pyrrolo-benzthiazole verfahren zu ihrer herstellung und diese verbindungen enthaltende arneimittel
DE69431199D1 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
DE3856329D1 (de) Verwendung von Ethisterone zur topischen Behandlung von Akne oder androgenetischer Alopezie
ATE239470T1 (de) Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen
ATE114468T1 (de) Ethyl-(+)-apovincaminat zur behandlung der demyelinisierung klinischer erscheinungen autoimmunen ursprungs.
DE3775278D1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
DE3879709D1 (de) Platin-arzneimittel.
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
DE3585312D1 (de) Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
DE68918449D1 (de) Siliziumverbindungen zur behandlung von knochen.
ATE127118T1 (de) 2-alkyl-3-benzoylbenzofurane zur behandlung von herzarrhythmia.
ATE74004T1 (de) Mischung zur behandlung von hypercholesterolemie.
ATE336282T1 (de) Katheter zur behandlung von prostaterkrankungen
DE69117566D1 (de) Verwendung von Isomonoolen zur Behandlung und Prophylaxe von Krebserkrankungen
ATE66780T1 (de) Zubereitung zur behandlung von psoriasis.

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Free format text: DERZEIT KEIN VERTRETER BESTELLT

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee